article thumbnail

The DDW Podcast: 2022 in review 

Drug Discovery World

Recombinant DNA technology and its impact on modern drug discovery . What can we learn from the genome? . Mini-library approach delivers an arsenal in drug development pipeline . Is genomic data the new frontier in drug discovery? . Sitting Down With . Narrated Podcasts.

article thumbnail

Beyond the Pill: The Rise of Biologics and the Evolution of Pharmaceutical Therapies

Cloudbyz

Unlike traditional small molecule drugs, which are chemically synthesized, biologics are produced through complex biotechnological processes, often involving recombinant DNA technology. Understanding Biologics: Biologics are a class of therapeutic agents derived from living organisms, such as cells, tissues, or proteins.

Gene 73
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Leading innovators in gene splicing using nucleases for the pharmaceutical industry

Pharmaceutical Technology

Innovation S-curve for the pharmaceutical industry Gene splicing using nucleases is a key innovation area in the pharmaceutical industry Nucleases play a fundamental role in the field of recombinant DNA technology, or genetic engineering. Nucleases are enzymes that hydrolytically cleave the phosphodiester backbone of DNA.

article thumbnail

Can artificial intelligence help craft new medicines?

Drug Discovery World

The potential of drug targets Over the next 50 years, new targets emerged and drugs were developed against them. Recombinant DNA technology and improved protein purification techniques further contributed to our understanding and explorations of drug targets. Thus, there was a dire need for new and effective drug targets.